Page last updated: 2024-08-24

bimakalim and Angina Pectoris

bimakalim has been researched along with Angina Pectoris in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burian, M; Mitrovic, V; Petkovic, D; Piske, M1
Hamm, C; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J1

Trials

2 trial(s) available for bimakalim and Angina Pectoris

ArticleYear
Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris.
    Cardiovascular drugs and therapy, 2004, Volume: 18, Issue:1

    Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Benzopyrans; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Potassium Channels; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Vasodilation

2004
Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
    Herz, 2000, Volume: 25, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Benzopyrans; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Cardiotonic Agents; Coronary Disease; Cyclopropanes; Dihydropyridines; Electrocardiography; Exercise Test; Gallopamil; Hemodynamics; Humans; Middle Aged; Myocardium; Oxygen Consumption; Potassium Channel Blockers; Potassium Channels; Propanolamines; Time Factors; Vasodilator Agents

2000